Kyle Mikson
Stock Analyst at Canaccord Genuity
(3.29)
# 1,020
Out of 5,127 analysts
121
Total ratings
41.94%
Success rate
5.25%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Hold | $130 → $150 | $117.25 | +27.93% | 15 | Jan 26, 2026 | |
| WGS GeneDx Holdings | Maintains: Buy | $160 → $170 | $91.24 | +86.32% | 3 | Dec 22, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $19 → $20 | $18.54 | +7.87% | 10 | Dec 22, 2025 | |
| TEM Tempus AI | Maintains: Buy | $95 → $80 | $57.12 | +40.06% | 3 | Dec 22, 2025 | |
| QTRX Quanterix | Maintains: Hold | $5 → $8 | $6.17 | +29.66% | 8 | Dec 22, 2025 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $2 → $1.5 | $1.07 | +40.19% | 6 | Dec 22, 2025 | |
| NTRA Natera | Maintains: Buy | $250 → $285 | $210.58 | +35.34% | 12 | Dec 22, 2025 | |
| GH Guardant Health | Maintains: Buy | $100 → $125 | $105.34 | +18.66% | 10 | Dec 22, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $37 → $50 | $32.23 | +55.13% | 6 | Dec 22, 2025 | |
| CAI Caris Life Sciences | Maintains: Hold | $28 → $30 | $22.31 | +34.47% | 2 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $85 → $105 | $103.32 | +1.63% | 10 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $105 | $100.40 | +4.58% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $40 → $43 | $36.73 | +17.07% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $150 → $165 | $143.58 | +14.92% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $15 | $3.37 | +345.10% | 5 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $20 | $9.93 | +101.41% | 5 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.84 | +63.04% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.23 | +143.90% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.25 | +691.45% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,476 | $10.95 | +13,385.61% | 1 | Mar 30, 2021 |
Illumina
Jan 26, 2026
Maintains: Hold
Price Target: $130 → $150
Current: $117.25
Upside: +27.93%
GeneDx Holdings
Dec 22, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $91.24
Upside: +86.32%
10x Genomics
Dec 22, 2025
Maintains: Buy
Price Target: $19 → $20
Current: $18.54
Upside: +7.87%
Tempus AI
Dec 22, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $57.12
Upside: +40.06%
Quanterix
Dec 22, 2025
Maintains: Hold
Price Target: $5 → $8
Current: $6.17
Upside: +29.66%
Quantum-Si incorporated
Dec 22, 2025
Maintains: Hold
Price Target: $2 → $1.5
Current: $1.07
Upside: +40.19%
Natera
Dec 22, 2025
Maintains: Buy
Price Target: $250 → $285
Current: $210.58
Upside: +35.34%
Guardant Health
Dec 22, 2025
Maintains: Buy
Price Target: $100 → $125
Current: $105.34
Upside: +18.66%
Castle Biosciences
Dec 22, 2025
Maintains: Buy
Price Target: $37 → $50
Current: $32.23
Upside: +55.13%
Caris Life Sciences
Dec 22, 2025
Maintains: Hold
Price Target: $28 → $30
Current: $22.31
Upside: +34.47%
Nov 25, 2025
Downgrades: Hold
Price Target: $85 → $105
Current: $103.32
Upside: +1.63%
Nov 17, 2025
Maintains: Buy
Price Target: $85 → $105
Current: $100.40
Upside: +4.58%
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $36.73
Upside: +17.07%
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $143.58
Upside: +14.92%
Oct 27, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $3.37
Upside: +345.10%
Sep 19, 2025
Maintains: Buy
Price Target: $30 → $20
Current: $9.93
Upside: +101.41%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.84
Upside: +63.04%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.23
Upside: +143.90%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.25
Upside: +691.45%
Mar 30, 2021
Initiates: Overweight
Price Target: $1,476
Current: $10.95
Upside: +13,385.61%